References
Ball SC (2004) Rapid neurologic deterioration in a patient with HIV infection. AIDS Read 14:63–66, 69
Berger JR, Sheremata WA, Resnick L, Atherton S, Fletcher MA, Norenberg M (1989) Multiple sclerosis-like illness occurring with human immunodeficiency virus infection. Neurology 39:324–329
Gray F, Lescs MC (1993) HIV-related demyelinating disease. Eur J Med 2:89–96
Gray F, Lescure FX, Adle-Biassette H, Polivka FM, Gallien S, Pialoux G, Moulignier A (2013) Encephalitis with infiltration by CD8+ Lymphocytes in HIV Patients receiving Combination Antiretroviral Treatment. Brain Pathol
Kepes JJ (1993) Large focal tumor-like demyelinating lesions of the brain: intermediate entity between multiple sclerosis and acute disseminated encephalomyelitis? A study of 31 patients. Ann Neurol 33:18–27
Langford TD, Letendre SL, Marcotte TD, Ellis RJ, McCutchan JA, Grant I, Mallory ME, Hansen LA, Archibald S, Jernigan T, Masliah E (2002) Severe, demyelinating leukoencephalopathy in AIDS patients on antiretroviral therapy. AIDS 16:1019–1029
Lindzen E, Jewells V, Bouldin T, Speer D, Royal W 3rd, Markovic-Plese S (2008) Progressive tumefactive inflammatory central nervous system demyelinating disease in an acquired immunodeficiency syndrome patient treated with highly active antiretroviral therapy. J Neurovirol 14:569–573
Nagappa M, Taly AB, Sinha S, Bharath RD, Mahadevan A, Bindu PS, Saini JS, Prasad C, Shankar SK (2012) Tumefactive demyelination: clinical, imaging and follow-up observations in thirty-nine patients. Acta Neurol Scand. doi:10.1111/ane.12071
Narciso P, Galgani S, Del Grosso B, De Marco M, De Santis A, Balestra P, Ciapparoni V, Tozzi V (2001) Acute disseminated encephalomyelitis as manifestation of primary HIV infection. Neurology 57:1493–1496
Netherton C, Moffat K, Brooks E, Wileman T (2007) A guide to viral inclusions, membrane rearrangements, factories, and viroplasm produced during virus replication. Adv Virus Res 70:101–182
Saravanan M, Turnbull IW (2009) Brain: non-infective and non-neoplastic manifestations of HIV. Br J Radiol 82:956–965
Uriel A, Stow R, Johnson L, Varma A, du Plessis D, Gray F, Herwadkar A, Holland J, Lewthwaite P, Wilkins E (2010) Tumefactive demyelination-an unusual neurological presentation of HIV. Clin Infect Dis 51:1217–1220
Virtanen JO, Jacobson S (2012) Viruses and multiple sclerosis. CNS Neurol Disord Drug Targets 11:528–544
Acknowledgments
Funding sources include National Institute of Allergy and Infectious Diseases (NIAID) (UM1AI069495) (DBC), National Institute of Mental Health (NIMH) (K23MH081786) (BMA), National Institute of Neurological Disorders and Stroke (NINDS) (U10NS077384) (DBC) and (F30NS063547) (IHS), National Institute of Nursing Research (NINR) (R01NR012907 and R01NR012657) (BMA), NM22005 (DBC), and Alzheimer’s Association (with partial support from Lilly and Roche) (BMA and DBC). DBC has consulted for Pfizer, Genzyme, Millennium, Brinker, Biddle, Reath, Amgen, Quintiles, Biogen Idec, Arnold Todara and Welch.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Solomon, I.H., Perrin, R.J., Clifford, D.B. et al. Tumefactive demyelination in a patient with human immunodeficiency virus. J. Neurovirol. 19, 265–269 (2013). https://doi.org/10.1007/s13365-013-0165-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13365-013-0165-y